Summary
Swedish researchers used national records to follow everyone who had sex reassignment surgery and changed legal sex between 1973 and 2003. They compared each person with ten random people of the same age and sex. Over about 11 years, the reassigned group died about three times as often and died by suicide about 19 times as often. They were about five times as likely to attempt suicide and three times as likely to be admitted for psychiatric care, even after allowing for earlier psychiatric admissions. The gaps in deaths and suicide attempts were mainly among people treated before 1989. The authors concluded that surgery, while easing gender distress, is not enough on its own, and better long-term care is needed. Because the comparison was with the general public, not trans people who did not transition, the study cannot say whether surgery made things better or worse.
Key findings
- 瑞典 1973 至 2003 年間接受性別重置手術並變更法定性別的全部 324 人(191 名男變女、133 名女變男),與 3,240 名出生年份和性別相同的一般民眾比較。
- 各種原因的死亡約為出生性別相同者的 3 倍,差距大約在 10 年後才拉開。
- 因自殺死亡約高出 19 倍,依據是 324 人中有 10 起自殺,而對照組為 5 起。真實數字非常不確定(可能介於約 6 倍到 63 倍之間)。
- 自殺未遂約高出 5 倍,精神科住院約高出 3 倍,即使考慮了手術前的精神科住院(變更性別組約為 4 倍)也是如此。
- 心臟與血管疾病的死亡略有增加(約 2.5 倍;9 人死亡),癌症死亡可能也有增加(約 2 倍)。作者提醒人數很少,並未將原因歸咎於荷爾蒙。
- 對於 1989 至 2003 年間接受治療的人,額外的死亡和自殺未遂可能只是偶然,不過精神科住院仍高出約 2.5 倍。
- 女變男者的刑事定罪比其他女性多,與男性大致相同;男變女者與其他男性沒有差異。
- 作者表示,這項研究無法顯示性別重置作為一種治療是否有效,而且若沒有手術,結果可能還會更糟。
Abstract
Context: The treatment for transsexualism is sex reassignment, including hormonal treatment and surgery aimed at making the person's body as congruent with the opposite sex as possible. There is a dearth of long term, follow-up studies after sex reassignment.
Objective: To estimate mortality, morbidity, and criminal rate after surgical sex reassignment of transsexual persons.
Design: A population-based matched cohort study.
Setting: Sweden, 1973-2003.
Participants: All 324 sex-reassigned persons (191 male-to-females, 133 female-to-males) in Sweden, 1973-2003. Random population controls (10:1) were matched by birth year and birth sex or reassigned (final) sex, respectively.
Main Outcome Measures: Hazard ratios (HR) with 95% confidence intervals (CI) for mortality and psychiatric morbidity were obtained with Cox regression models, which were adjusted for immigrant status and psychiatric morbidity prior to sex reassignment (adjusted HR [aHR]).
Results: The overall mortality for sex-reassigned persons was higher during follow-up (aHR 2.8; 95% CI 1.8-4.3) than for controls of the same birth sex, particularly death from suicide (aHR 19.1; 95% CI 5.8-62.9). Sex-reassigned persons also had an increased risk for suicide attempts (aHR 4.9; 95% CI 2.9-8.5) and psychiatric inpatient care (aHR 2.8; 95% CI 2.0-3.9). Comparisons with controls matched on reassigned sex yielded similar results. Female-to-males, but not male-to-females, had a higher risk for criminal convictions than their respective birth sex controls.
Conclusions: Persons with transsexualism, after sex reassignment, have considerably higher risks for mortality, suicidal behaviour, and psychiatric morbidity than the general population. Our findings suggest that sex reassignment, although alleviating gender dysphoria, may not suffice as treatment for transsexualism, and should inspire improved psychiatric and somatic care after sex reassignment for this patient group.
Conclusion
Persons with transsexualism, after sex reassignment, have considerably higher risks for mortality, suicidal behaviour, and psychiatric morbidity than the general population. Our findings suggest that sex reassignment, although alleviating gender dysphoria, may not suffice as treatment for transsexualism, and should inspire improved psychiatric and somatic care after sex reassignment for this patient group.